Sort
21,281 grants matching “influenza”
Project 1
$486,580Octavio Ramilo · St. Jude Children'S Research Hospital · U19 · FY2024 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$486,541Richard Rothman · Johns Hopkins University · N01 · FY2018 · AI
Host response to post-operative pneumonia
$486,318State University Of New York At Buffalo · R01 · FY2004 · AI
IMPROVEMENT OF THE COTTON RAT MODEL OF HUMAN DISEASES
$486,173Virion Systems, Inc. · R24 · FY2002 · RR
Project II: Immunity to Influenza in Primary Lung Dendritic Cells
$485,972Stuart C. Sealfon · Icahn School Of Medicine At Mount Sinai · U19 · FY2017 · AI
Alveolar responses to viral lung infection
$485,947Jaime Lynn Hook · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HL
Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.
$485,840Mark M Davis · Stanford University · U19 · FY2022 · AI
Harlem Community Academic Partnership: Influenza Immunizations
$485,769David H Vlahov · University Of California, San Francisco · R24 · FY2011 · MD
Influenza vaccine failure in adults over age 75: role of chronic CMV infection
$485,624Sean X Leng · Johns Hopkins University · R01 · FY2014 · AI
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis
$485,623Matthew Bryan Frieman · University Of Maryland Baltimore · R01 · FY2013 · AI
Mechanisms of regulatory T cell-mediated recovery from severe influenza A virus infection
$485,530Benjamin David Singer · Northwestern University At Chicago · R01 · FY2024 · HL
Pandemic Potential of H5N1 Influenza Viruses
$485,519Yoshihiro Kawaoka · University Of Wisconsin-Madison · R01 · FY2008 · AI
Exercise-induced immunomodulation in the aged
$485,479Marian L Kohut · Iowa State University · R01 · FY2009 · AI
Rapid olfactory tools for telemedicine-friendly COVID-19 screening and surveillance
$485,408Steven D Munger · University Of Florida · U01 · FY2021 · DC
Development of Broadly Immunogenic and Universal Influenza Virus Vaccines
$485,313Audray Harris · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Molecular Analysis of Pathogens in Otitis Media by PCR
$485,305Allegheny-Singer Research Institute · R01 · FY2004 · DC
Task C2: Analytical Method, Process Development and Manufacturing for Therapeutics
$485,288Isabel Scholz · Nanotherapeutics, Inc. · N01 · FY2023 · AI
Protective humoral immunity to influenza infection
$485,276Nicole Baumgarth · University Of California At Davis · R01 · FY2020 · AI
Protective humoral immunity to influenza infection
$485,276Nicole Baumgarth · University Of California At Davis · R01 · FY2019 · AI
Protective humoral immunity to influenza infection
$485,276Nicole Baumgarth · University Of California At Davis · R01 · FY2017 · AI
Protective humoral immunity to influenza infection
$485,276Nicole Baumgarth · University Of California At Davis · R01 · FY2018 · AI
Proteoglycan-Chemokine Interactions in Lung Disease
$485,256Pyong Woo Park · Boston Children'S Hospital · R01 · FY2020 · HL
Proteoglycan-Chemokine Interactions in Lung Disease
$485,256Pyong Woo Park · Boston Children'S Hospital · R01 · FY2019 · HL
Proteoglycan-Chemokine Interactions in Lung Disease
$485,256Pyong Woo Park · Boston Children'S Hospital · R01 · FY2017 · HL
Mucosally-delivered HA stem binding antiviral for influenza
$485,210Deborah L. Fuller · University Of Washington · R33 · FY2019 · AI